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ABSTRACT 
 
SUPEROXIDE DISMUTASE INHIBITOR SCREENING AND CHARACTERIZATION 
USING 19F NMR  
Megan Elizabeth Arrington, M.S. 
Western Carolina University (March 2010) 
Director: Jack Summers, Ph.D. 
 
Superoxide dismutase enzymes (SOD) catalyze the disproportionation of superoxide to 
form molecular oxygen and hydrogen peroxide in a cyclic mechanism.  SODs prevent 
the formation of hydroxyl radicals, preventing apoptosis.  Up-regulation of this enzyme 
implicates it in the survival of cancer cells and pathogenic bacteria, leading to a call for 
SOD inhibitors as potential drugs.  19F NMR based assays were used to study inhibition 
of CuZnSOD by flavonol compounds.  Flavonols are more effective inhibitors at high pH.  
We hypothesize that inhibition at high pH occurs through a two-step reaction, where the 
first step is an equilibrium reaction affected by the deprotonation of the inhibitor and the 
second step is slower and affected by the deprotonation of the enzyme.  The pH 
dependence of the second inhibition step is consistent with enzyme deprotonation of 
active site Lys 122 at pH=10.1 and is not necessary for the first step.  It was also 
observed that aggregation of flavonol inhibitors may be occurring and therefore flavonol 
binding is stronger than experimentally measured. 
 To understand the factors that affect binding of flavonols to CuZnSOD, AutoDock 
4.0 calculations were carried out and compared to experimental binding constants at pH 
8.  Experimental binding data show that flavonol diketone tautomerization is not 
necessary for binding and that inhibitors bind more effectively above their pKa1 values.  
 
 
Bis-deprotonated, enol and S-diketone tautomers were predicted to bind CuZnSOD 
preferentially in docking results.  Computational results indicate that lysine and arginine 
residues contribute significantly to binding by hydrogen bonding with flavonol 3,7, and 4'-
oxygens.  Despite a strong overall correlation between docking scores for the 
deprotonated species and experimental results, apigenin was predicted to have a higher 
binding affinity than is experimentally observed.  The underlying cause of this 
discrepancy is a matter of further investigation.
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1. INTRODUCTION 
 
1.A. Superoxide 
 Superoxide is a radical anion produced by metabolic pathways in the body 
through the reduction of molecular oxygen.1    After it is produced, superoxide can react 
with other biological molecules by either univalent oxidation or reduction.2  It may also 
form the hydroxyl radical through the Fenton reaction, where superoxide acts by 
reducing iron as shown in Equation 1A and 1B.3 
 
. 3 2
2 2O Fe O Fe
− + +
+ → +  (1A) 
 
2 . 3
2 2H O Fe OH OH Fe
+ − +
+ → + +  (1B) 
The hydroxyl radical is a reactive oxygen species, which can modify nucleic acids and 
proteins through oxidation.  The formation of reactive oxygen species by superoxide 
leads to oxidative stress.1   
  
1.B. Superoxide Dismutase 
 Superoxide is a natural product of aerobic metabolism and is often produced in 
large quantities (107 radicals per day in rat mitochondria)1 therefore; a reaction of 
superoxide must be present to protect the cell from damage.4  The superoxide 
dismutation reaction was first proposed by McCord and Fridovich4 and is shown in 
Equation 2. 
 
. .
2 2 2 2 22O O H O H O
− − +
+ + → +  (2) 
In the dismutation reaction, one superoxide molecule is oxidized and the other is 
reduced resulting in the formation of molecular oxygen and hydrogen peroxide.4  The 
overall reaction of superoxide is catalyzed by the enzyme superoxide dismutase.  
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Superoxide dismutases (SODs) contain metal cofactors, which catalyze the reaction as 
shown below in Equation 3A and 3B.5 
 
. ( 1)
2 2
n nM O M O+ − − ++ → +  (3A) 
 
( 1) .
2 2 22
n nM O H M H O− + − + ++ + → +  (3B) 
The reaction of superoxide catalyzed by SOD prevents oxidative stress, as superoxide 
would otherwise form the hydroxyl radical, which is cytotoxic.2  The SOD reaction has a 
rate constant of 5 x 1011 M-1s-1, showing that this enzyme has extremely high activity, 
making it extremely efficient at converting superoxide to hydrogen peroxide and 
important to cell survival.6   
 
1.C. Targeting Superoxide Dismutase 
 Superoxide is generated by antibiotics to induce oxidative stress in bacterial 
cells.  Kohanski et al. showed that bactericidal antibiotics kill bacterial cells through the 
production of hydroxyl radials from superoxide via the Fenton Reaction.7  One possible 
way to increase antibiotic efficacy is to interfere in the processes that protect cells from 
superoxide and the hydroxyl radical.7  Inhibiting superoxide dismutase would increase 
the bacteria's sensitivity to these reactive oxygen species,8 making it easier to kill the 
cell.  SOD is critical to oxidation-reduction potential balance and is implicated in many 
diseases from cancers8 and Amyotrophic Lateral Sclerosis9 to malaria10 and 
tuberculosis.7  For this reason, there has been a call for the development of SOD 
inhibitors as drugs. 
 Recent research shows that superoxide dismutase inhibitors have potential as 
drugs.  In 2000, Huang et al. examined the use of oestrogen derivatives as inhibitors of 
SOD in leukemia cells.8  They determined that 2-methoxyestradiol selectively inhibited 
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human SOD, killing leukemia cells while preserving the healthy lymphocytes.   The 
inhibition of SODs resulted in free-radical damage of mitochrondial membranes, 
releasing cytochrome c and causing apoptosis.8  This result shows that one can inhibit 
SOD, cause oxidative stress and ultimately kill cells selectively.  Other known inhibitors 
are metal chelating agents11 such as diethyldithiocarbamate12 and small anions such as 
azide, cyanide and hydroxide that compete for the enzyme's active site.8  These 
inhibitors are poor drug candidates as they are non-specific and potentially cytotoxic.8 
 
1.D. SOD Assays 
High throughput SOD assays have to be used to screen libraries of molecules for 
inhibition.  Using the natural substrate, superoxide, as a model for selecting inhibitors is 
not a possibility.10  Traditionally, the screening for SOD targets has involved the use of 
SOD assays, which observe superoxide reactions.13  SOD assays involve the generation 
of superoxide from an enzymatic (xanthine oxidase) or non-enzymatic (NADH/PMS 
system) source.  The generated superoxide reduces a detector molecule (NBT or 
ferricytochrome c) and the absorbance is measured.13  Assays, which use an enzymatic 
source of superoxide, may be inaccurate for high throughput screening (HTS) as 
molecules could inhibit the superoxide source.10  Soulere discovered that SOD assays 
that generate superoxide are not selective enough for HTS because screening 
compounds can affect the redox balance of the assay.10  Compounds, which interfered 
with the assay, showed either apparent inhibition or 'superoxide dismutase-like' activity 
suggesting that superoxide reacted with library compounds.10  This result shows that 
assays that do not involve superoxide generation must be used for accurate high 
throughput screening. 
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1.E. 19F NMR Based Assays 
 19F NMR assays use the fluoride anion as a superoxide mimic, where an inhibitor 
would compete with fluoride for the active site.14  Viglino, et al. established the use of 19F 
NMR as a CuZnSOD assay.14  They measured the T1 and T2 relaxation rate constants of 
19F- as a function of oxidized CuZnSOD concentration and determined that fluoride 
coordinates to the copper and that the rate of binding controls the T2 relaxation rate of 
fluoride.14  The relaxation of fluoride is so sensitive to the presence of CuZnSOD that 10-
8 M concentrations can be detected.14  Compounds that inhibit CuZnSOD (azide and 
cyanide) were also found to inhibit the relaxation of fluoride.14  This shows that 
relaxation can be used as an indirect detector of inhibition and thus be used for 
compound screening. 
 The 19F NMR assay was further developed by Summers15 for high throughput 
screening of superoxide dismutase inhibitors.  The relaxation rate of fluoride is sensitive 
to the presence of oxidized SOD14; therefore, 100 catalytic units per 600 µL sample can 
be detected with a low field strength spectrometer.15  As shown in Figure 1A and 1B, the 
resonance of the internal reference, trifluoroacetate (tfa), is less sensitive to relaxation 
by the enzyme, while the presence of active superoxide dismutase greatly diminishes 
the peak intensity of the fluoride anion.15 
 
 
Figure 1. Effect of SOD on 
tfa (5 mM) and F¯ (20 mM NaF) solution (40 ms relaxation).  B. Effect o
 
 Trifluoroacetate is consistently less affected by the presence of active SOD when 
compared to the fluoride anion.  The application of pulse delay and refocusing allows 
time for the F- signal to relax, enhancing of the differences between the integrals.
natural logarithm of the ratio of tfa and F
concentration of the enzyme as shown in Figure 2.
Figure 2.  Ratio of tfa to fluoride 
 
 The concentration of active enzyme [
measurement using Equation 4. 
19F spectra.  A. 1 transient CPMG spectrum of diamagnetic 
Cu/Zn SOD. 
- integrals [ln(Itfa/IF-)] is directly proportional to the 
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19F Resonance Integrals Correlate with SOD 
Concentration.15 
SODAc] can be calculated from a single 
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f ~100 units 
16  The 
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 1 2
[ ] ln tfa
F
I
Ac ISOD C C−= +  (4)
 
In which Itfa/IF- is the ratio of resonance integrals and the constants (C1 and C2) are 
based on the resonances' sensitivity to relaxation by the enzyme, the delay and 
concentrations of F- and tfa.  A benefit of using this method is the elimination of the need 
for shimming between samples as the loss in field homogeneity is indicated in the 
resonance loss of tfa.15  
 
1.F. Phytoestrogen CuZnSOD Inhibition 
 Using the 19F NMR based assay, the effect of 2-methoxyestradiol (2ME) on 
CuZnSOD activity was measured.15  Huang, et al reported an inhibitory concentration of 
20 µM.8  We were unable to observe inhibition at 100 µM at neutral pH using the NMR 
based assay.  An alternative method described by Rigo17 using the detection of 
superoxide had the same result.  This result was possibly caused by poor solubility of 2-
methoxyestradiol at neutral pH.  As Huang, et al.8 achieved inhibition in a 50 mM 
carbonate solution; the pH was likely to be above 9.3 resulting in an increased solubility 
due to the deprotonation of the phenol proton.  The experiment was repeated at pH 10.3 
containing 50 mM carbonate, resulting in complete inhibition. 
 Since inhibition by 2-methoxyestradiol was not observed at neutral pH, we 
decided to look for other compounds that inhibit SOD at alkaline pH.  We reasoned that 
the 2ME phenol group deprotonation was important and decided to look at other 
compounds containing phenols.  Seven phytoestrogens18 were screened for inhibition of 
CuZnSOD at 50 µM and pH 10.3.  Of these quercetin was found to inhibit with an IC50 of 
640 nM.15  Quercetin only varies slightly in structure from the inactive compound 
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apigenin c; quercetin has hydroxyl groups at R1 and R2 while apigenin c does not, the 
overall structure shown in Figure 3. 
 
Figure 3. General Flavonol Structure. 
 
 We noted that quercetin but not apigenin inhibits CuZnSOD.   These two 
compounds differ by the presence of alcohol groups at R1 and R2 in quercetin that are 
not present in apigenin. This observation and the binding of 2-methoxyestradiol to 
CuZnSOD lead our group to hypothesize that the catechol moiety on the B ring (shown 
in Appendix C) of quercetin may be important to binding.  To further assess the role of a 
catechol moiety in binding, kaempferol was screened for inhibition.  It was found that 
kaempferol inhibited at alkaline pH with an IC50 of 160 µM.  Kaempferol was found by 
Sharma, et al. to increase the effect of doxorubicin (a chemotherapy agent) and 
increased oxidative stress causing apoptosis in glioblastoma cells.19  These findings and 
research completed by our group demonstrate the potential of flavonoids as CuZnSOD 
inhibitors. 
 Described in this thesis is the inhibition of CuZnSOD by flavonol compounds.  
We also describe our efforts to increase throughput for screening.  A main goal of this 
study was the development of a flavonol structure-activity relationship using 19F NMR 
kinetic studies and docking calculations.  The inhibition of 19F relaxation by known 
CuZnSOD inhibitors, showed the ability of this assay to screen and characterize 
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inhibitors for SODs.  High throughput screening was performed using a 500-compound 
library obtained from the Chemical Methodologies and Library Development Center at 
the University of Pittsburgh.  Also, additional compounds were screened for their 
potential ability to inhibit.  Compounds found to inhibit CuZnSOD or MnSOD have 
potential as anti-cancer8 and anti-bacterial drugs.7  Structure activity relationships can 
help further development of inhibitors with increased binding affinity and specificity. 
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2. MATERIALS AND METHODS 
 
2.A. CuZnSOD and MnSOD Standardization 
 75,000 unit samples of enzymes CuZnSOD and MnSOD were obtained from MP 
Biomedicals LLC.  Enzymes were diluted to 1mL with HPLC H2O and 2 µL enzyme 
solution was removed and added to 600 µL stock NaF solution.  The enzyme sample 
activity was determined using the CPMG16 method (Eq. 9) and the amount of enzyme 
adjusted until the appropriate relaxation rate was obtained (30-100 s-1).  The enzyme 
solution was divided into portions of approximately 3000 units (40 µL) and dehydrated 
using centrifuge evaporation.  Once the samples had been evaporated, they were 
placed in the freezer until needed.  For inhibition studies, a portion was diluted to 200 µL 
with HPLC H2O to make stock solution.  10 µL of stock CuZnSOD was added per 600 µL 
sample.  The amount of MnSOD needed was significantly smaller than for CuZnSOD, 
therefore only 2-3 µL of MnSOD was needed per 600 µL NMR sample.  The amount of 
SOD necessary to produce an appropriate relaxation rate increases with pH, and thus 
additional SOD was added to samples at alkaline pH. 
 
2.B. Stock Solution Preparation 
2.B.1. Sample Solution Overview 
NMR solutions were prepared with sodium fluoride (NaF) and buffer in 10% deuterium 
oxide (D2O).  Samples for high throughput screening also contained sodium 
trifluoroacetate (Natfa) as an internal reference.  The internal reference, Natfa, was 
prepared from 1:1 mole ratios of trifluoroacetic acid and NaOH at 200 mM 
concentrations and then diluted to 2 mM for sample stock solution.  Sodium fluoride 
aqueous solution was prepared at 40 mM or 200 mM concentrations and was often 
20 
 
included in buffer solution of the same concentration.  They were diluted to 20 mM for 
NMR studies. 
 
2.B.2. Buffer Preparation 
 Buffers for pH dependence studies were prepared with pH ranging from 3 to 
11.6.  The buffers are listed in Table 1.  For inhibitor screening at physiological pH, 
PIPES buffer was used.  Buffers were prepared at 40 mM or 200 mM concentrations 
with sample solutions containing 20 mM buffer. 
Table 1. Buffers Used in Sample Preparation at Various pH Values. 
pH BUFFER 
3  Citric acid 
3.5 2-Chloropropionoic acid 
5 Sodium Acetate/Acetic acid 
6-8 Pipes or HEPES 
8-9 Tris 
9-11 Glycine 
10.5-11.5 Triethylamine 
11-12 Na2HPO4 
 
 Citric acid, chloropropionoic acid, Na2HPO4 and acetate buffers were used for the 
pKa determination of flavonols.  An additional buffer, sodium borate (Na2B4O7) was used 
to dissolve acetophenone compounds at pH 8.53.  Triethylamine was prepared and used 
almost immediately while other buffers were stored at room temperature.   
 
2.B.3. Preparation of Assay Controls 
 All experiments were conducted with a positive (SOD) control and a negative 
control.  Negative controls contained stock solution: 20 mM NaF/buffer solution with 10% 
D2O.  Controls for screening also contained 2 mM Natfa.  Positive (SOD) controls 
contained stock solution with a given amount of SOD enzyme (i.e. 10 µL of CuZnSOD 
per 600 µL of sample solution).  This solution was vortexed and used for the positive 
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control and inhibitor samples were prepared so as to contain a homogeneous amount of 
enzyme.  Controls and samples solutions were maintained at a temperature of 25 °C 
throughout experiments. 
 
2.C. 19F NMR Based Screening 
 In this project, we employed the NMR based assay first reported by Viglino14 and 
later developed by Summers20 to screen a large number of chemical compounds for 
their abilities to inhibit SODs. The assay measures the effect that the oxidized form of 
superoxide dismutase has on 19F NMR relaxation.15  The relaxation rate of the fluoride 
anion is very sensitive to SOD.14  This allows for the determination of SOD concentration 
from the relaxation rate of fluoride.  The one dimensional CPMG16 method described in 
the introduction section 1.E. was used for the qualitative screening of molecules for SOD 
inhibition. 
  
2.D. HTS Activity Determination 
 Screening was done using the 19F NMR based assay described in the 
introduction section 1.E.  Inhibition was determined from the ratio of the resonance 
integrals of tfa and F-.  As shown in Figure 1 of the introduction, the presence of active 
SOD increases F- relaxation while having little effect on the relaxation of tfa.  Therefore, 
an inhibited sample should have an increased resonance integral for F-, yielding a 
smaller ratio.   Compounds, which yield smaller ratios, are potential binders with 
complete inhibition being reflected by a return to the ratio of the negative control or an 
almost complete restoration of enzyme activity.  The enzyme activity was determined 
according to Equation 5 from the ratio of resonance integrals (I) for tfa and F-. 
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ln( ) ln( )
ln( ) ln( )
tfa tfa
F F
tfa tfa
F F
I I
Sample NegControlI I
I I
SODcontrol NegControlI I
Activity
− −
− −
−
=
−  (5)
 
Compounds, which showed some decrease in activity, were rescreened. 
 
2.E. CPMG Pulse Sequence 
 Inhibitors were characterized using 19F NMR and the CPMG16 pulse sequence 
equipped on the JEOL Eclipse 300 NMR at Western Carolina University.  The CPMG 
pulse sequence consists of a 90° pulse followed by a delay  of τ, then a 180° pulse 
followed by a delay of 2τ and another 180° pulse.16  After time τ, the nucleus is in the y-
axis and the signal is observed in the y-direction from time 4τ to 40τ, observing the 
signal decay with time.16  The integral (I) of each signal at time (t), where t = 4τ, 8τ... 
40τ, can be described by Equation 6. 
 
2
0
R tI I e−=  (6) 
Equation 6 relates the signal integral (I) to the relaxation rate (R2), which describes how 
the signal decays with time.  Origin was used to integrate the signal at time t and 
determine the relaxation rate, according to Equation 7. 
 0 2ln( ) ln( )I I R t= −  (7) 
 2 [ ]AcR k SOD=  (8) 
Where the relaxation rate (R2) is determined from the linear change in the resonance 
integral (I) with time, t.  Since the relaxation rate is directly related to active enzyme 
concentration, as shown in Equation 8, the CPMG method can be used to accurately 
measure the active SOD concentration and SOD activity.16  The R2 values were used to 
determine the CuZnSOD activity of each sample as shown in Equation 9. 
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2, 2,
2, 2,
Sample NegControl
SODcontrol NegControl
R R
Activity
R R
−
=
−  (9)
 
R2 values from this method were used to determine activity for inhibitor kinetics studies. 
 
2.F. Enzyme Inhibition Kinetics 
 The CuZnSOD inhibition kinetics were characterized for flavonol compounds and 
9-anthracenecarboxylic acid.  Observed rate constants (kobs) were determined at alkaline 
pH for flavonols and apparent rate constants (kapp) across pH range 7 to 10.9 for ACA.  
Observed rate constants are determined from apparent rate constants as shown in 
Equation 10. 
 
[ ]
app
obs
k
k
Inh
=  (10) 
Where [Inh] is the flavonol inhibitor concentration and kapp is determined below, 
according to Equation 11A and 11B.  Activity was measured using either the screening 
method (Eq. 5) or the CPMG method (Eq. 9).  The activity was observed to decay 
exponentially with time as shown in Equation 11A.  Plots of the logarithm of the activity 
versus time were linear as shown in Equation 11B. 
 0
appk tA A e−=  (11A) 
 0ln lnappA k t A
−= +  (11B) 
 Where A is the activity determined from the NMR study over time and A0 is the 
initial activity of enzyme determined from y-intercepts of plots of log A versus time.  We 
expected that A0 would equal the activity of the enzyme in the absence of inhibitor or 
would equal the activity of the control.  We observed, however that A0 was significantly 
less than the activity of the control.  We attribute the difference to an initial equilibrium 
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step that results in less than 100% initial activity at t=0.  This initial inhibition step can be 
characterized by the dissociation constant Kd as shown in Equation 12A and 12B.   
 dAc InAcK
SOD Inh SOD+ ←→
 (12A)
 
 
[ ][ ]
[ ]
Ac
d
InAc
SOD Inh
K
SOD
=
 (12B)
 
Where [SODAc] is the concentration of active SOD, [SODInAc] is the inactive or inhibited 
SOD concentration, and [Inh] is the monomeric inhibitor concentration.  If %SODAc + 
%SODInAc = 100%SOD, the Kd can be re-written in terms of active SOD (%SODAc) as 
shown in Equation 13A.  The dissociation constant is inversely related to 1/%SODAc -1 
as shown below in Equation 13B.   
 
%
[ ]
1 %
Ac
d
Ac
SOD
K Inh
SOD
=
−  (13A) 
 
[ ] 1
1
%d Ac
Inh
K SOD
= −
 (13B)
 
 Kd values were determined for myricetin, morin and 2,4,6-
trihydroxyacetophenone from the relationship between initial activity (A0) and the 
concentration of inhibitor ([Inh]).  The relationship between initial activity ((1/A0)-1) and 
inhibitor concentration [Inh] was not linear for flavonol compounds, myricetin and morin.  
We believe this was due to aggregation of the flavonols above certain concentrations.  
Maximum Kd values were obtained from the initial linear relationship between initial 
activity and flavonol concentration.  The dissociation constant is defined where the 
concentration of inhibitor [Inh] refers to the monomeric concentration only.  Flavonol 
concentrations may actually be less than experimentally measured, as flavonol 
molecules may not be in monomeric form because of aggregation.  Larger forms do not 
inhibit the enzyme; therefore, as aggregation occurs and the concentration of the 
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monomer decreases, the dissociation constant decreases.  For this reason, reported 
dissociation constants are observed maximum values not best fit values.   
 The dimerization of flavonol inhibitors can be described by Equation 14A with a 
dimerization constant (Kdim) shown in Equation 14B.   
 
dim
2
KInh Inh Inh+ ←→  (14A) 
 
2
dim 2 2
[ ] [ ][ ]
[ ] 2[ ]
totInh InhInhK
Inh Inh
−
= =
 (14B)
   
Where [Inhtot] is the total (experimental) inhibitor concentration and [Inh] is the total 
monomeric inhibitor concentration.  The dimerization constant determines the actual 
concentration of monomeric inhibitor [Inh], which is the active species that inhibits SOD.  
The monomeric inhibitor concentration [Inh] is related to the total inhibitor concentration 
by the quadratic equation shown in Equation 15. 
 
dim
dim
1 1 8 [ ]
[ ]
4
totK InhInh
K
−
+ +
=
 (15)
 
The best fit of the Kd and Kdim values to the data was calculated from the difference 
between calculated and experimental values of (1/A0)-1 using least squares analysis.   
 
2.G. pH Dependence of Inhibition Kinetics 
 The inhibition of CuZnSOD by 9-anthracencecarboxylic acid (ACA) was studied 
across the pH range 7 to 11.6.  The apparent rate constant (kapp) was measured for the 
1mM ACA inhibition of CuZnSOD from pH 7 to 11.6 using the CPMG method.  Activity 
was determined using R2 values (Eq. 9), and the apparent rate constants calculated 
(Eq.11B).  The relationship between pH and the apparent rate constant was fitted with a 
pH titration curve and the pKa estimated. 
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2.H. Aggregation Experiments 
 Using UV-Vis spectroscopy, the effect of concentration on absorbance was 
measured for myricetin and kaempferol.  Samples were prepared with varying 
concentrations of flavonol in a solution of 20 mM buffer and NaF.   Flavonols were 
dissolved in DMSO at 50 times the sample concentration so that the addition of 20 µL 
flavonol to 1 mL of 20 mM buffer/NaF solution would yield an overall concentration of 2% 
DMSO.  Blanks were prepared in a similar manner with the addition of DMSO in lieu of 
flavonol solution to yield 2% DMSO sample solution.  Kaempferol samples contained 
11.6, 23.3, 46.5, 93, 186 µM concentrations of flavonol and were prepared with PIPES 
buffer at pH 7.94.  For the initial myricetin experiment, the samples contained 3.1, 
6.2,12.3, 24.6, 36.9, 49.3 µM concentrations of myricetin with the same buffer used in 
the kaempferol experiment.  Absorbance was measured using a Hewlett-Packard model 
8453 UV-Vis spectrometer with a 1 centimeter quartz cuvette. 
 Kaempferol and myricetin were the only flavonols examined in this aggregation 
study.  However, all flavonols are structurally similar and are likely to aggregate.  At pH 
7.94, a Beer's law plot was generated for kaempferol at 274 and 382 nm.  A Beer's Law 
plot was not generated for myricetin because the absorbance was greater than 2.5 
absorbance units for 3 µM to 50 µM myricetin.  The experiment was repeated using a 
SpectraMax microplate reader because it uses a smaller pathlength, allowing us to 
measure absorbance without decreasing the sample concentration.  Samples were read 
vertically instead of horizontally, therefore the pathlength was determined by the volume 
of the sample instead of the dimensions of the cuvette.  100 µL samples were measured 
in triplicate in a quartz SpectraPlate #R8024, which is usable down to 190 nm.  The 
resulting absorbance at 220 nm was compared to the initial activity from the NMR study 
in the same concentration range. 
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2.I. High Throughput Screening 
2.I.1. Compound Preparation 
 500 compounds were obtained from the Chemical Methodologies and Library 
Development Center at the University of Pittsburgh for a proof of concept study of high 
throughput screening.  The average mass of the compounds was 400 g/mole and each 
had a mass of 0.5 mg.  Compounds were diluted to 2.5 mM in 500 µL dimethylsulfoxide 
(DMSO) solution.  50 µL portions were sent in well plates to the Bruker BioSpin 
Corporation for high throughput screening and the remaining 450 µL portions frozen.  
12.5 µL portions of the 2.5 mM compounds were added to 600 µL samples to yield 50 
µM samples in 2% DMSO solution. 
 
2.I.2. Bruker Sample Preparation and CuZnSOD Screening 
 Sample solution was prepared at 10 times the sample (10X) concentrations at pH 
7.16 using PIPES buffer.  Positive (SOD) and negative controls were prepared from 
stock solution.  CuZnSOD enzyme was prepared by combining 25 standardized JSJM1 
SOD portions so that 5 - 1 mL enzyme portions contained enough enzyme solution for 
500 samples of 10 µL each.  The enzyme was solution was evaporated for shipping.  
The 10X stock solution, controls, and enzyme were sent along with 500-50 µL portioned 
compounds in DMSO solution to be analyzed on an NMR equipped with a SampleJet 
sample changer (Bruker BioSpin, Inc.).  Amy Freund of the Bruker BioSpin Corporation 
completed the sample preparation and analysis, which included the dilution of samples 
with 10% D2O and the addition of CuZnSOD and compounds.  All inhibitor screening 
was completed using the 19F NMR based assay and inhibition determined from tfa and F- 
resonance integral ratios.   
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2.I.3. CuZnSOD Rescreening and MnSOD Screening 
 CuZnSOD samples were rescreened on the JEOL Eclipse 300 NMR at Western 
Carolina University.  Compounds showing reduced activity were re-prepared and 
screened.  The same 500 compounds were also screened for inhibition of MnSOD.  To 
decrease the amount of stock solution and enzyme needed for screening, the 
compounds were screened five at a time. This was done by combining 12.5 µL portions 
of 5 different compounds into a single well in a plate.  They were then vortexed using a 
microplate mixer yielding a solution of 5 compounds at 500 µM each.  12 µL portions of 
the 125 5-compound solutions were added to 600 µL MnSOD samples and screened.  
500-12.5 µM compounds were screened in 125 samples in approximately two hours, at 
a rate of approximately 5 compounds per minute. 
 
2.J. Selective Inhibitor Screening 
2.J.1. Flavonol Screening 
 Flavonol molecules were screened against CuZnSOD using the 19F NMR based 
assay.  Samples were prepared with stock solution containing 20 mM NaF, 2 mM Natfa, 
10% D2O and 20 mM glycine buffer at pH 10.59.  Flavonols were dissolved in DMSO to 
yield 2.5 mM solution and diluted for 2% DMSO samples.  Taxifolin, morin, galangin and 
kaempferol were screened at 50 µM while fisetin and quercetin were screened at 10 µM 
and 5 µM respectively.  The activity was measured from the tfa and F- resonance 
integrals (Eq. 5) and observed rate constants determined (Eq. 10). 
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2.J.2. Benzoic Acid, Diketone, and Chalcone Screening 
 Using the 19F NMR screening method, benzoic and boronic acids and pyridines 
were screened for SOD inhibition.  Stock solution was prepared with 20 mM buffer/NaF, 
2 mM tfa (internal reference) and 10% D2O.  Compounds were dissolved in DMSO.  The 
boronic and benzoic acids and pyridine compounds listed in Table 2 were screened for 
inhibition of CuZnSOD at 1 mM and pH 10.59 with glycine buffer. 
Table 2. Compounds Screened for Inhibition of CuZnSOD at 1 mM and pH 10.59. 
BENZOIC ACIDS BORONIC ACIDS PYRIDINES 
Benzoic acid 4-carboxyphenyl boronic acid Picolinic acid 
2,4-dihydroxybenzoic acid 4-formylphenyl boronic acid Nicotinic acid 
Allyl ether of benzoic acid 8-quinoline boronic acid  
9-anthracenecarboxylic acid 5-isoquinoline boronic acid  
5-nitroisophthalic acid   
 
 9-anthracencecarboxylic and 2,4-dihydroxybenzoic acids were rescreened for 
activity at pH 7.26 using PIPES buffer.  1 mM glyoxal and 10 mM 2,4-pentanedione were 
screened against CuZnSOD at pH 10.44 using glycine buffer.  Chalcones21 were 
prepared by Professor Jack Summers and screened for MnSOD inhibition at 50 µM and 
pH 10.44 (structures in Appendix A).  Activity was determined using the screening 
method (Eq. 5).   
 
2.J.3. Acetophenone Screening 
 The effect of 2,4,6-trihydroxyacetophenone (THAP) and 4-hydroxyacetophenone 
(4HAP) on CuZnSOD activity was measured using the CPMG method.  Acetophenone 
compounds were dissolved in 1:1 concentrations of borate buffer prepared from 
Na2B4O7.  Samples were prepared 1:1 from 2X acetophenone solution and 2X stock 
solution.    The effects of THAP were determined at concentrations from 37 µM to 9 mM 
in 10 mM borate at pH 8.58.  4HAP was screened from 0.2 to 20 mM at pH 8.53 in 20 
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mM borate buffer and at pH 10.59 using TEA buffer.  Activity was determined using the 
resulting R2 values (Eq. 9). 
 
2.K. Flavonol pKa Determination 
 Acid dissociation constants were measured for morin, myricetin, taxifolin and 
galangin using UV-Vis spectroscopy.  Solutions contained 20 mM NaF, 20 mM buffer 
solution, and 50 µM concentrations of the respective flavonol.  Buffers from Table 1 were 
used to make samples across the pH range 3 to 11.6 for each flavonol.  Absorbance 
was measured using a Hewlett Packard model 8453 UV-Vis spectrometer with a quartz 
1-centimeter pathlength.  For morin, myricetin and taxifolin, pKa values were estimated 
using Excel by plotting the absorbance at wavelengths 351 and 391, 370 and 322, and 
288 and 326 nm, respectively.  Professor Scott Huffman determined galangin pKa 
values. 
 
2.L. Mass Spectrometry of Quercetin Inhibited CuZnSOD 
 Quercetin and enzyme samples were prepared for analysis by mass 
spectrometry.  Samples contained CuZnSOD and 20mM ammonium acetate buffer 
(NH4OH/NH4OAc) at pH 10.05 and did not contain NaF or Natfa.  Quercetin was 
prepared by dissolving 0.0298 grams of quercetin in 1 mL DMSO, followed by a dilution 
to 2.46 mM.  Enzyme solution was prepared by combining two portions (6000 units) of 
standardized CuZnSOD in 200 µL HPLC H2O.  The effect of ammonium acetate buffer 
on enzyme activity was measured by adding 5 µL portions of SOD to 600 µL NMR stock 
solution containing 20 mM NaF, 20 mM ammonium acetate buffer and 10% D2O.  The 
activity was determined using the CPMG method. 
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 The remaining portion of CuZnSOD was divided into two portions and each 
diluted to 500 µL with 20 mM ammonium acetate buffer.  10 µL of 2.46 mM quercetin 
was added to one of the 500 µL CuZnSOD samples to yield 49.3 µM quercetin in 2% 
DMSO solution.  The activity was measured for both samples over a two-day period in 
order to observe the complete decrease in activity for the quercetin-CuZnSOD sample 
and to make sure the activity did not decrease after the dehydration of the CuZnSOD 
sample.  The remaining 450 µL sample solutions were dehydrated and kept frozen until 
samples were ready for analysis.  Michael Samuel at Wake Forest University ran both 
samples under direct infusion with trapping column and then backwashed the sample to 
the QTOF mass spectrometer.  Initial samples were prepared in a similar manner by 
Professor Jack Summers and ran by Professor David Evanoff on the Thermo LTQ Mass 
Spectrometer at Western Carolina University. 
 
2.M. Docking Calculations 
2.M.1. eHiTS Docking Calculations 
 Initial calculations were performed using the eHiTS docking program but it was 
found to be insufficient and results for which are not reported in this thesis.  CuZnSOD 
and ZndefSOD active site models were constructed in Sprout from pdb files 1PU022 and 
2R27,9 respectively.  The CuZnSOD model was docked in eHiTS version 5.9 
(SymBioSys, Inc.) using tautomeric forms of the known inhibitors quercetin and 
kaempferol.  Initial results showed the inhibitors binding outside of the active site.  A 
dummy ligand (cyclopentane) was then inserted into the active site to indicate the 
preferred binding region.  Despite, this modification, eHiTS did not produce meaningful 
results.  Likely because eHiTS does not account for flexible side chains and arginine and 
lysine side chains were observed to obstruct the active site suggesting that flexible 
 
residues affect access to and shape of the CuZnSOD active site.  To accommodate for 
flexibility, definitive docking calculations have been performed using AutoDock 4.0.
 
2.M.2. Ligand Preparation
 Molecular models of 2,4,6
apigenin, kaempferol, myricetin, quercetin and taxifolin were prepared in all of their 
physiologically meaningful tautomeric and protonation states.  Musialik determin
protonation states and acid dissociation constants of flavonoids from their structure 
affinity relationships.24  From the available pK
states are expected at pH 8.
Figure 4. Tautomers of Quercetin: Enol (A), R
 
Initial conformations and partial atomic charges were generated using the 'equilibrium 
conformer' utility in Spartan '04 with a semi
cases, convergence problems were addressed by
au.26  Ligand structures were then saved using the Tripos mol2 format with charges 
included.   These files were then converted to the default AutoDock pdbqt format, which 
adds a specification as to which torsions are to
calculations.  By default, all rotable torsions were set to flexible.
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2.M.3. Receptor File Preparation 
 The receptor file, 1PU022 for wild-type human SOD, was downloaded from 
Brookhaven and edited to monomeric form without the active site Zn and Cu ligands.  
This protein model spawned errors in AutoDock due to slight angular inaccuracies in the 
disulphide bridges. To correct this problem, we used the Anneal program in Sybyl27 to 
conduct a localized minimization on all disulphide bridges, using the TRIPOS force field 
without electrostatics.  Next, electrostatic and Van der Waals parameters for the copper 
and zinc cofactors were added to the AutoDock 'parameters.dat' file so that the docking 
calculations could take into account the potential influence of these highly charged 
atoms.   
 To ensure the most accurate electrostatic representation of the SOD, protonation 
states of ionizable residues and overall partial atomic charges were calculated at pH 8 
using the finite-difference Poisson-Boltzmann solver in PDB2PQR28 web server courtesy 
of Dolinsky, et al.  The resulting pqr file was parsed into two files: one file describing the 
rigid part of the binding site and the other describing the flexible part of the site; (‘rigid’ 
and ‘flex’ pdbqt files, respectively) using AutoDockTools.29  Flexible residues specified in 
the flex file are: Lys122, Lys 136, Thr137, and Arg143.  The rigid file was generated with 
60 x 60 x 50 Å grid centered around the active site copper.  Metal cofactors were edited 
back into the rigid receptor file as PDB2PQR28 does not recognize copper and zinc 
cofactors.  Docking calculations were performed using AutoDock 4.023 on MAC OS X for 
preliminary calculations and subsequent calculations were performed on a 4 dual-core 
CPU Linux workstation.   
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2.M.4. AutoDock Analysis 
 Results from AutoDock were examined by comparing the energies and distances 
of various poses for each ligand and then ligands were compared between compounds.  
A pose is the conformation of the ligand in the receptor active site and the confirmation 
of the specified flexible amino acid residues.  Poses are calculated by AutoDock and 
have binding energies associated with them.  Distance constraints were applied so that 
a pose with an average distance greater than 10 Å from Arg143 was not considered.  
Arginine 143 is in the center of the active site and a ligand this far from the active site is 
not likely to represent a physically realistic binding pose. The distances between the 
guanidinium carbon of arginine 143 and the 7-position oxygen and the 3-position carbon 
were measured using the measureDistanceGC tool in AutoDockTools.29  These specific 
flavonol positions were chosen because the 7-position oxygen is the site of the first 
deprotonation and the 3-position carbon is the site of tautomerization.24 
 Once unrealistic poses were ruled out, the top five binding poses for each 
species of each ligand was plotted as a function of the logarithm of experimental 
dissociation constants, Kd
30 for each protonation state.  Trends between species and 
dissociation constant were observed to gain a global understanding of what species of 
ligand is/are likely to bind.  This approach revealed that bis-deprotonated ligands are 
likely the binding species.  Individual bis-deprotonated poses were studied to gain an 
understanding of what types of interactions occurred for a specific ligand.  
Understanding the interactions for each ligand can explain why some flavonols are 
stronger binders than others.  It can also show what ligands have in common in terms of 
interactions to predict what functionality is necessary for flavonol binding.  For this 
analysis, acetophenones were not considered, as they are structurally different enough 
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for it to be inappropriate to include them in the development of the structure affinity 
relationship for flavonols.   
 To observe global trends in binding energies; individual poses exhibiting specific 
interactions with a given residue or a ligand functional group were plotted as a function 
of logKd
30 for each ligand.  A correlation between experimental and predicted binding 
energy of these poses helps uncover what functional groups and residues may be 
important for binding.  Our experimental design was put in place to help determine what 
state of our ligands are most likely to bind, while specific trend analysis of individual 
ligands predicts why differences in binding exists and final global analysis predicts what 
groups and residues are involved in binding.  The combination of these three analyses 
guides the prediction of the structure activity relationship, which can be used to guide the 
development of new inhibitors and optimize inhibition. 
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3. RESULTS AND DISCUSSION 
 
3.A. Flavonol Inhibitor Screening 
3.A.1 Flavonol Observed Rate Constants 
 Several flavonol molecules were screened for inhibition of the CuZnSOD enzyme 
at alkaline pH.  The observed rate constants (kobs) of each were determined and are 
reported in Table 3. 
Table 3. Observed Rate Constants for Various Flavonols at pH 10.59 
 
Structure Compound kobs (µM
-1s-1) 
 
Quercetin 5.2 x 10-4 
 
Fisetin 4.6 x 10-4 
 
+/- Taxifolin 1.2 x 10-4 
 
Morin 1.18 x 10-4 
 
Galangin 1.04 x 10-4 
 
Kaempferol 6.6 x 10-5 
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 The observed rate constants reported in Table 3 show what structural features 
influence inhibition.  When comparing the observed rate constant and structure of 
quercetin to that of other the inhibitors, the following inferences can be made.  Inhibition 
is not caused by interactions with the 5-hydroxyl group.  This is suggested by 
comparative kobs values for fisetin and quercetin when the 5-hydroxyl group has been 
removed in the former.  What did seem influential on the inhibition of CuZnSOD are the 
substituents on the B ring (shown in Appendix C).  The removal of the 5'-hydroxyl group 
results in decreased inhibition for kaempferol and galangin.  The movement of the 
hydroxyl group from the 5' to 6' position in morin also decreases the inhibition constant. 
   
3.A.2. Arginine Modification 
 We hypothesized that inhibition could involve arginine modification.  It was found 
that apigenin did not inhibit CuZnSOD while quercetin inhibited quickly at alkaline pH.  
Kaempferol, an intermediate between quercetin and apigenin, inhibits the enzyme 
though not as well as quercetin, suggesting that the 3-hydroxyl group is necessary for 
inhibition.  The enol may be necessary for inhibition because it can tautomerize to the 
diketone moiety, which may be necessary for the inhibitor's activity.  If this is true, the 
diketone may react according to the reaction in Figure 5, reported by Gilbert and 
O'Leary.31 
 
Figure 5.  Reaction of 2,4-Pentanedione with Arginine forms N-substituted 2-amino-4,6-
dimethylpyrimidine.31 
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 In the reaction of arginine with 2,4-pentanedione, Gilbert and O'Leary found that 
the diketone of 2,4-pentanedione reacted with the guanidinium moiety of the arginine to 
form a pyrimidine ring with N-substituted 2-amino-4,6-dimethylpyrimidine being the only 
product.31  Further evidence of CuZnSOD inhibition by arginine modification is the 
modification by p-hydroxylphenylglyoxal resulting in the deactivation of bovine pancreatic 
ribonuclease A as reported by Yamasaki32 and the reaction of 1,2-cyclopentanedione 
with arginine to form DHCH-arginine33 reported by Smith.34  If such a mechanism is 
present, the diketone moiety of the flavonol tautomer may react with the active site 
residue arginine 143, an important residue for CuZnSOD function.5 
 
3.A.3. 2,4-Pentanedione and Glyoxal Screening 
 To test this hypothesis, both 2,4-pentanedione and glyoxal were screened for 
inhibition.  It was found that 10 mM 2,4-pentanedione did not inhibit the enzyme at pH 
10.44 while 1 mM glyoxal did.  Further characterization of inhibition by glyoxal was 
performed by Jonathan Markley.  As 2,4-pentanedione does not inhibit the enzyme, 
inhibition of CuZnSOD cannot be by the reaction shown in Figure 5.  However, the 
diketone in 2,4-pentanedione has an additional carbon compared to the diketone moiety 
of the flavonol inhibitors; therefore, modification of arginine residues cannot be 
completely rejected as a means of inhibition by this result alone.   
 
3.A.4. Diketone Tautomerization 
 To test the diketone hypothesis, we screened taxifolin for inhibition at 50 µM and 
determined the observed rate constant as shown previously in Table 3.  The structure of 
taxifolin differs from that of quercetin by reduction of the 2-3 double bond.  This 
difference in structure results in two structural differences: taxifolin is unable to 
39 
 
tautomerize to the diketone form and a new chiral center is formed.  The results in Table 
3 show that taxifolin inhibits, although less effectively than quercetin.  The inhibition of 
CuZnSOD by taxifolin shows that the diketone moiety is not necessary for inhibition.  
This result suggests that inhibition does not occur due to reactions with arginine and a 
diketone.  This helps refute the hypothesis that inhibition occurs through arginine 
modification by a diketone similar to the reaction reported by Gilbert and O'Leary.31 
 Although inhibition of CuZnSOD does not occur due to arginine modification, the 
effect of tautomerism on molecular shape may still play a role in the increased 
effectiveness of quercetin as compared to luteolin.  Luteolin inhibition was examined by 
Jonathan Markley because it also lacks the ability to tautomerize and has only one 
isomer whereas taxifolin has four.  In luteolin, the removal of the 3-hydroxyl group, 
results in a lower Kd of 830 µM
30 and renders it unable to tautomerize.  Taxifolin has sp3 
hybridization at the 2-carbon while luteolin and quercetin are planar due to sp2 
hybridization.  To determine the contribution of sp3 hybridization to binding, eriodictyol 
was screened for inhibition by Erin Parris and Corey Harrington as it is similar in 
structure to luteolin (structure given in Appendix D).  This compound was found to only 
inhibit partially at high concentration and pH 8.5.  This result shows that tautomerism to 
give a non-planar shape of flavonols is not the origin of the difference in behavior of 
quercetin and luteolin.   
 
3.B. pH Dependence of CuZnSOD Inhibition 
3.B.1. Acidic Inhibitor Screening 
 Our group previously measured the effect 100 µM 2-methoxyestradiol (2ME) has 
on CuZnSOD.  This compound was reported by Huang to inhibit.8  Inhibition was only 
achievable after the addition of 50 µM carbonate at pH 10.3 suggesting that the 
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deprotonation of the molecule is necessary for inhibition.  As flavonols are structurally 
similar to 2ME, they too should show pH dependence and this has consistently been the 
case.  In order to understand the origin of this pH dependence, the screening for more 
acidic inhibitors was carried out.  The boronic and benzoic acids and pyridine carboxylic 
acids, given in the Materials and Methods section 2.J.2., were screened for inhibition of 
CuZnSOD.  Of these 2,4-dihydroxybenzoic acid and 9-anthracenecarboxylic acid were 
found to inhibit at alkaline pH. 
 
3.B.2. Determination of Enzyme Acid Dissociation Constant 
 Of the compounds screened for CuZnSOD inhibition, 2,4-dihydroxybenzoic acid 
and 9-anthracenecarboxylic acid were found to inhibit the enzyme at alkaline pH.  At pH 
7.26, 9-anthracenecarboxylic acid (ACA) was found to inhibit CuZnSOD completely but 
slower than at alkaline pH while 2,4-dihydroxybenzoic acid only slightly decreased the 
enzyme's activity.  ACA appears to have pH dependent activity over the pH range 7 to 
10.9 and has a pKa of 3.66;
35 therefore, the pH dependence of inhibition cannot be 
caused by deprotonation of the molecule but by some change in the enzyme.  To further 
examine this, the effect of pH on the apparent rate constant was measured and the plot 
fitted with a standard titration curve with a pKa of 10.1, as shown in Figure 6. 
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Figure 6. Effect of pH on the Apparent Rate Constant of CuZnSOD Inhibition by 1 mM 9-
Anthracenecarboxylic acid. 
 
3.B.3. Possible Enzymatic Causes of pH Dependence 
 The trend line in Figure 6 represents behavior predicted for an acid with an acid 
dissociation constant of 10.1.  As the pKa of ACA is far below this range, the 
deprotonation event causing pH dependence belongs to the enzyme, specifically an 
active site residue with a pKa of 10.1.  The active site residue lysine 122 was determined 
to have a pKa of 10.1 by Argese and Viglino
36 using NMR and crystallographic data.  
This residue partially controls the electrostatics of the enzyme along with lysine 136.36  
This suggests that decreased enzyme activity may be caused by the deprotonation of 
lysine 122.36  Another possible cause of the pH dependence of CuZnSOD is the gradual 
denaturation of the enzyme.  However, the enzyme control sample retained activity, 
ruling out loss of activity due to changes in electrostatics or denaturation.  Additionally, 
the enzyme denaturation is reported to only occur after pH 12.5.37   
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3.B.4. Replication of Enzyme Acid Dissociation Constant 
 The pH dependence of CuZnSOD inhibition by ACA was repeated in order to 
replicate the results showing an enzyme deprotonation at pH 10.1.  Kinetic data was 
collected at pH 10.59 in order to compare the rate constant to that reported in Figure 6.  
This experiment resulted in an apparent rate constant (kapp=0.0007 s
-1) an order of 
magnitude lower than the previous experiment (kapp=0.0055 s
-1).  However, this was not 
consistent across the pH range 7 to 11, and the determination of the acid dissociation 
constant was irreproducible.  This may be due to the difference in the enzyme between 
standardized samples, which needs to be addressed in future experiments. 
 
3.B.5. Acetophenone Screening 
 Using a different acidic inhibitor may yield more information about the pH 
dependence of the flavonol inhibition.  Inhibition by acetophenones has been 
investigated.  2,4,6-trihydroxyacetophenone (THAP) is similar in structure to flavonol 
molecules as shown in Figure 7.   
 
 
Figure 7. Structure of 2,4,6-Trihydroxyacetophenone (left) as Compared to the Flavonoid 
Structure (right). 
 
The effect of THAP on initial activity is shown in Figure 8 with dissociation constant Kd of 
3.5 mM at pH 8.58.   
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Figure 8.  Inhibition of CuZnSOD by THAP at pH 8.58. 
 
 THAP was also examined for the purpose of determining the distances between 
the copper atom of CuZnSOD and individual protons using 1H NMR experiment.  These 
distances can be compared to computational data from AutoDock and used to help 
verify docking results.  However, single pulse H NMR spectra show that the inhibitor is 
oxidizing in the air.  Future experiments using acetophenones will involve using an air-
free system.  Another acetophenone, 4-hydroxyacetophenone (4HAP), shown in Figure 
9, is less prone to oxidation and was screened for activity at pH 8.5.     
 
 
Figure 9. Structure of 4-Hydroxyacetophenone. 
 
 A concentration dependence experiment showed little change in initial activity 
with concentration, ranging from 0.2 to 20 mM.  The compound was rescreened for 
inhibition at pH 10.59 for 20 mM 4HAP.  The activity of the enzyme decreased from 97% 
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initial activity to 87% activity 21 hours later; therefore, this compound is an extremely 
poor binder of CuZnSOD. 
 
3.C. Enzyme Kinetics 
3.C.1. Kinetic Data Indicate Rapid Pre-Equilibrium 
 Upon addition of the inhibitor, it was observed that the initial activity of the 
enzyme was not 100%, an example of which is shown in Figure 10, where 100% activity 
would be indicated by a value of zero for the intercept. 
 
Figure 10. CuZnSOD Inhibition by 1 mM ACA at pH 8.58. 
 
The initial loss of activity indicates an initial binding step between the enzyme and ACA.  
The effect of varying ACA concentration on CuZnSOD inhibition was measured at pH 
8.58 from 62.5 to 1000 µM using the CPMG method.  Altering inhibitor concentration 
changed the initial activity of the enzyme as illustrated in Figure 11.  This suggests that 
there is a quick equilibrium inhibition reaction occurring between CuZnSOD and the 
inhibitor.  A second inhibition step was also observed as the activity of the enzyme 
continues to decrease slowly over time, shown in Figure 10 above.   
-1.4
-1
-0.6
-0.2
0.2
0 20 40
lo
g(
A
ct
iv
ity
)
time (hours)
45 
 
 
Figure 11.  Concentration Dependence of Initial Activity Indicates an Equilibrium 
Reaction with a Dissociation Constant Kd of 1mM for ACA. 
 
3.C.2. Effect of pH on Initial Activity 
 The inhibition of CuZnSOD at high pH appears to be a two-step reaction.  As 
discussed in Section 3.B.3., the pH dependence of CuZnSOD may be caused by the 
deprotonation of the active site residue, lysine 122.  This is not desirable in an inhibitor 
because it cannot be necessary to change the body's pH in order to deprotonate an 
enzyme and achieve inhibition.  To determine of the initial binding step is affected by 
enzyme deprotonation, the initial activity of CuZnSOD inhibition was examined as a 
function of pH as shown in Figure 12. 
 
Figure 12. Effect of pH on the Initial Activity of CuZnSOD Inhibition by 1 mM ACA. 
 
 Where the initial activity, A0 varied within uncertainty around 60% activity and is 
not pH dependent.  We conclude that the initial binding step is pH independent.  This 
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shows that the deprotonation of the enzyme is not necessary for binding but functions to 
increase the rate constant of the second slower inhibition reaction.  These results lead 
us to propose the mechanism of inhibition in Equation 16, in which the deprotonation of 
the enzyme increases the rate constant, k2 of the second step. 
 
2
1 2d
k
Ac InAc InAcK
Inh SOD InhSOD InhSOD+ ←→ →  (16) 
  
3.C.3. Effect of Flavonol Protonation State on Dissociation Constant 
 The protonation state of enzyme has been shown to have little effect on the initial 
binding of ACA.  This step appears to be influenced by the protonation state of the 
inhibitor and therefore, can still be affected by pH.  To access this possibility, the effect 
that pH has on the equilibrium dissociation constant Kd was measured for myricetin and 
morin, as shown in Table 4.   
Table 4.  Dissociation Constants for Myricetin and Morin. 
Compound pH Kd,max (µM) pKa1 pKa2 
Myricetin 5.48 332 6.515  
 7.94 9.3   
Morin 830 600 5.224 8.224 
 8.99 408   
 
These pH values were selected for myricetin, as they are above and below the first acid 
dissociation constant for the molecule.  Myricetin has a pKa1 value of 6.5 as determined 
by UV-Vis spectroscopy; the pKa2 value was not determined.  This means that the Kd 
values for pH 5.48 and 7.94 correspond respectively to the binding of the protonated and 
singly deprotonated forms of myricetin to CuZnSOD.  As a lower dissociation constant 
means a stronger binder, the deprotonated form of myricetin present at pH 7.94 is the 
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more effective binder.  The same is shown for morin, as increased binding is observed 
above the pKa2 of morin, perhaps indicating that the bis-deprotonated form is more 
effective than that deprotonated. 
 
3.D. pH Dependence of CuZnSOD Inhibition Considerations 
 When considering that both the protonation state of the inhibitor and the enzyme 
affect inhibition, the system becomes very complicated.  Measurements of various 
inhibitors must be done at the same pH so as to compare inhibition against the same 
enzyme and not forms with varied protonation states.  For this reason and to better 
compare flavonol inhibition results to docking results, flavonol dissociation constants Kd 
were re-measured at pH 8 by Jonathan Markley.  These results will be discussed in 
context with the docking calculations in a later section. 
 
3.E. Myricetin and Kaempferol Aggregation 
 As discussed in the Materials and Methods section, CuZnSOD inhibition by 
flavonols appears to compete with flavonol dimerization.  This was first considered when 
the initial activity was observed to change nonlinearly with the concentration of Myricetin 
as shown in Figure 13. 
 
Figure 13.  Initial Activity Changes Non-linearly with Myricetin Concentration at pH 7.94. 
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 To further study aggregation, the effect of concentration on absorbance was 
measured for myricetin and kaempferol by UV-Vis spectroscopy.  A Beer's Law plot was 
generated for kaempferol at pH 7.94 from 11.6 to 186 µM.  As shown in Figure 14, 
kaempferol no longer obeyed Beer's Law above 50 µM. 
 
Figure 14.  Beer's Law Plot of Kaempferol at pH 7.94. 
 
 For the inhibitor, myricetin, absorbance was measured from 3 to 50 µM at pH 8.  
A peak shift near 230nm was observed with an absorbance greater than 2.5 absorbance 
units with increasing concentrations from 3 to 50 µM myricetin.  Since the absorbance 
was too high to quantify this shift using UV-Vis spectrometer, measurements were 
repeated using a microplate reader.  Upon repeating the experiment, a nonlinear change 
in absorbance at 220 nm was observed and compared to the inhibition data.  Figure 15 
shows that both inhibition and absorbance change in the same non-linear way as the 
total concentration of myricetin is increased.   
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Figure 15. Concentration Dependence of Initial Activity and Absorbance for Myricetin at 
pH 8. 
 
 In the absence of aggregation, absorbance should correlate with concentration 
according to Beer's law.  Figures 14 and 15 show that this is not the case.  A possible 
explanation is that the concentration may be not increasing in a linear fashion.  This 
would occur if the concentration of myricetin monomer were not equal to the total 
myricetin concentration, caused by aggregation.  The increase in concentration results in 
a decrease in slope of the initial activity suggesting that the aggregates do not have the 
same effect on CuZnSOD as the myricetin monomer.  This suggests that only the 
monomeric form of myricetin inhibits CuZnSOD while aggregates do not.  Using 
fluorescence and UV-Vis spectroscopy, further analysis of aggregation was completed 
by Jonathan Markley.   
 Dimerization of flavonols can be characterized by a dimerization constant (Kdim) 
defined by Equations 14A and 14B, where Kdim = [Inh2]/[Inh]
2.  Using least squares 
analysis, the best fit of Kdim and Kd was calculated as described in the Materials and 
Methods section 2.F.  In Table 5, the estimated dimerization and dissociation constants 
are reported for myricetin at pH 7.94 only, as the other dimerization constants were so 
low as to consider dimerization minimal.  Other reported Kd values are maximum values 
discussed earlier in this thesis. 
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Table 5.  Estimated Dimerization and Dissociation Constants for Myricetin and Morin. 
Compound pH Kdim (µM
-1) Kd (µM) 
Myricetin 5.48  332 
 7.94 2.22E-01 3.3 
Morin 8.99  408 
 
 As the dissociation and dimerization constants both affect the fit of the curve to 
the data, uncertainty in Kdim will cause uncertainty in Kd.  For this reason, Kd,max values 
are discussed instead of estimated Kd values because the experimental values are more 
reliable. 
 
3.F. Determination of Flavonol Acid Dissociation Constants 
 UV-Vis spectroscopy was used to determine the pKa values for myricetin, 
taxifolin, morin and galangin.  pKa2 values were not determined for myricetin and 
taxifolin.  Acid dissociation constants were later found in the literature for taxifolin and 
galangin.  Using excel and calculations completed by Professor Scott Huffman, pKa 
values were estimated, in Table 6.   
Table 6. Flavonol pKa Values Determined by UV-Vis Spectroscopy. 
 pKa1 pKa2 
Myricetin 6.5  
Taxifolin 6.7  
Morin 4.8 7.9 
Galangin 7.19 9.44 
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3.G. High Throughput Screening 
 This study was conducted to show that the 19F NMR based assay could be used 
to screen large quantities of compounds quickly.  For this proof of concept experiment, 
500 compounds from the Chemical Methodologies & Library Development Center at the 
University of Pittsburgh were screened against two targets: CuZnSOD and MnSOD at 
pH 7.26.  Amy Freund of the Bruker BioSpin Corporation screened these compounds 
against CuZnSOD using a SampleJet sample changer (Bruker BioSpin, Inc).  None were 
found to inhibit CuZnSOD. 
 At Western Carolina University, samples were rescreened for activity and several 
compounds showed marginally decreased SOD activity, suggesting that inhibition may 
be occurring.  Re-preparation of the samples showed little change in enzyme activity.  All 
500 compounds were screened against MnSOD and none of these samples were found 
to inhibit the bacterial enzyme.  Chalcones were also screened for inhibition of MnSOD 
at alkaline pH and none inhibited.  Chalcone molecules were screened as Soulere found 
they inhibit FeSOD in Plasmodium falciparium and as MnSOD and FeSOD are similar in 
structure, it is possible a compound that inhibits one may inhibit the other.10 
 The failure to discover new inhibitors cannot be used to refute the concept of 
using 19F NMR based assays as a method for SOD inhibitor screening.  This experiment 
did show that the assay can be used to screen for inhibitors quickly as 500 compounds 
were screened in only 2 hours.  If this screening method were paired with high 
throughput screening docking calculations, a very large library could be narrowed down 
and screened very quickly while increasing the chance of finding inhibitors. 
 
  
 
3.H. Quercetin Inhibition of CuZnSOD Observed by Mass Spectrometry
 In order to understand where the inhibitor quercetin is binding in the active site of 
CuZnSOD, active and inhibited enzyme samples were analyzed using mass 
spectrometry.  Professor Jack Summers prepar
inhibited with quercetin for analysis at Western Carolina University.  Analysis by David 
Evanoff resulted in no observed molecular ion and the CuZnSOD
showed a decrease in viscosity as compared to the acti
were re-prepared after it had been determined that sample conditions did not affect 
CuZnSOD activity.  Michael Samuel, using quadrupole time
analyzed them at Wake Forest University.  Resulting mass sp
16A and 16B for CuZnSOD and quercetin inhibited CuZnSOD samples respectively.
 
Figure 16A. Mass Spectrum of 2500 Units of Active CuZnSOD.
ed samples of CuZnSOD and CuZnSOD 
-quercetin sample 
ve enzyme sample.  Samples 
-of-flight mass spectrometry, 
ectra are shown in Figures 
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Figure 16B. Mass Spectrum of 2500 Units of CuZnSOD Inhibited with 50
  
 Figure 16A shows mass to charge ratios as high as 50,000 while 16B only shows 
ratios up to 1800.  As CuZnSOD has an approximate molecular weight of 32,000,
samples should have peaks around 32000 for the singly charged enzyme and 16000 for 
the doubly charged enzyme.  The mass spectrum of active CuZnSOD in Figure 16A, 
reflects the presence of enzyme with a molecular ion peak at 15592 and a second 
smaller peak at 15690.  The mass spectrum of inactive CuZnSOD shown in Figure 16B, 
does not show this molecular ion peak nor does it show any smaller peaks which would 
be represent enzyme fragments.  The presence of only solvent peaks suggests that no 
enzyme was present in the sample, even though enzyme was added to both samples in 
equal amounts.  Since the enzyme was present in both samples, the lack of a molecular 
ion peak or fractions could be due to the enzyme never reaching the spectrometer.  This 
can be explained by possible precipitation of the enzyme from solution.  This hypothesis 
is supported by the observed decrease in viscosity in the CuZnSOD
compared to the active CuZnSOD sample.
-quercetin sample as 
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3.I. Docking Calculations 
3.I.1. Global Analysis 
 In order to understand the inhibitor binding interactions with CuZnSOD, docking 
calculations were performed using AutoDock 4.0.23  If our models are correct, then 
docking should predict the structure activity relationship for the binding of flavonols 
discussed earlier.  These include lower Kd values above an inhibitor's pKa observed for 
myricetin and morin (reported in Table 4) and the observed trend in Kd values at pH 8 
(given in Appendix B).  Based on these trends, docking calculations should predict 
deprotonated ligands will bind stronger than neutral ligands and compounds to bind with 
decreasing effectiveness in the following order: myricetin > quercetin > taxifolin > 
kaempferol >> apigenin > 2,4-dihydroxyacetophenone > 2,4,6-trihydroxyacetophenone.  
Both have been observed to be the case.   
 The global trend analysis shows that bis-deprotonated binding poses correlate to 
the experimentally determined dissociation constants as shown in Figure 17C.  Figures 
17A and 17B show the box charts of pose binding energies for neutral and deprotonated 
ligands respectively.  Box and whisker plots represent the statistical variation in the 
binding energy of docking poses: boxes show the 25th, 50th, and 75th percentiles and 
whiskers, the 10th and 90th percentiles.  The circles show the highest and lowest 
binding energies or the extrema and squares represent the average or mean binding 
energy. 
 
Figure 17A. Neutral Ligand Pose Bi
Data.  Box and whisker plots represent the statistical variation in the binding energy of 
docking poses: boxes show the 25th, 50th, and 75th percentiles and whiskers, the 10th 
and 90th percentiles.  The cir
extrema and squares represent the average or mean binding energy.
Figure 17B. Deprotonated ligand pose binding energies do not correlate with 
nding energies do not correlate with Experimental 
cles show the highest and lowest binding energies or the 
experimental binding constants. 
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Figure 17C. Bis-deprotonated flavonols are predicted to bind favorably as pose binding 
energies correlate to experimentally determined dissociation constants.
 
 Acetophenones were excluded from the trend analysis for bis
ligands, as they are only mono
analysis for each protonation state still shows bis
experimental data the best.  Individual poses correlating to experimental Log 
were enol and S-diketone tautomer s
tautomers appear more likely to bind than R
predicts apigenin to be a better binder than observed experimentally.  This discrepancy 
could be due to inaccuracies in the mo
 Inaccuracies in the model can originate from shortcomings of forcefield based 
docking.  One such inaccuracy is the inability of AutoDock 4.0
interactions in the docking calculation.   The conjugated 
interact with lysine and arginine residues in the active site through such interactions; the 
docking calculations may not fully characterize the binding because it ignores this 
-deprotonated 
-anionic.  Excluding acetophenones, the global trend 
-deprotonated ligands to fit the 
pecies. This predicts S-enantiomers of diketone 
-enantiomers.  The trend analysis also 
del and/or errors in the experimental data.  
23 to account for 
π system of flavonols could 
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possibility.38  Other possible sources of inaccuracies include the exclusion of water from 
the active site39 and the inability of AutoDock to account for changes in metal 
coordination.38  The exclusion of water discounts possible hydrogen bonding 
interactions, which may occur between the ligand and active site water molecules but 
the inclusion of water could also block the active site when the ligand displaces water.38 
 
3.I.2. Analysis of Specific Ligands 
 Individual bis-deprotonated ligand poses were analyzed to determine what 
interactions may lead to ligand binding.  Recall, a pose is the conformation of the ligand 
and flexible amino acid residues in the active site, which is calculated along with that 
conformation's binding energy by AutoDock.  This will be used later to identify 
differences and similarities in binding between ligands.  Hydrogen bonding interactions 
were examined for individual poses and the orientation of residues observed for each 
ligand.   
 
3.I.2.a. Myricetin  Myricetin binds the strongest to the enzyme with a Kd of 11µM.  It was 
observed that Arginine143 and Lysine 122 interacted significantly with the ligand, with all 
poses showing some interaction with Arg143 and 10 out of 15 poses showing 
interactions with Lys122.  Enol and S-diketone species were observed to hydrogen bond 
with the 3 and 4-position oxygens, which may be partially responsible for enzyme 
inhibition as discussed in section 2.I.1.  Some poses also show Arg143 and Lys 136 
hydrogen bonding with each side of the B ring (shown in Appendix C), which could 
explain why myricetin is a stronger binder than quercetin as myricetin has the additional 
3'-hydroxyl group on the phenol ring, which permits this interaction.  Myricetin was 
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observed to have a diverse set of poses with no single orientation being repeated 
multiple times. 
 
3.I.2.b. Quercetin  Quercetin also exhibits a diversity in its poses yet consistently has 
Lys122, Arg143 and Thr 137 oriented toward the ligand with Arg143 contributing 
significantly to binding with 13 out of 15 poses exhibiting Arg143 interactions.  
Frequently, in enol and S-diketone species, Arg143 interacts with the 3 and 4- position 
oxygen while this not observed at all for the R-diketone species.  The R-diketone poses 
show Arg143 interacting with the deprotonated 7-oxygen and lysine with the B ring in 
such a way that almost sandwiches the ligand.  This is occasionally observed in the 
other species of ligand as well and may contribute to binding. 
 
3.I.2.c. Taxifolin  Taxifolin is similar in structure to quercetin as shown in Table 3, with 
taxifolin differing by a reduction of the enol at the 2-3 bond.  This results in taxifolin's 
inability to tautomerize to the diketone species and results an increase in its observed 
dissociation constant.  Global analysis showed that taxifolin 2S isomers reproduced 
experimental trends in binding and were analyzed further through trend analysis.  This 
revealed two main clusters of species: the lower energy cluster belonging to 2S3S 
species and the higher energy cluster belonging to 2S3R species, with the exception of 
the lowest energy pose overall being 2S3R at -3.97 kcal/mol.  This lowest energy pose 
shows Arg143 hydrogen bonding to the deprotonated 7-oxygen and Lys122 to the 
deprotonated 4'-oxygen on the phenol, essentially sandwiching the ligand.  2S3S poses 
showed two main orientations of Arg143: one that maximizes hydrogen bonding of 
guanidinium hydrogens and the other that appears to be stacking of the guanidinium 
above the ligand π system suggesting π -cation interactions.  2S3R showed fewer lysine 
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interactions than 2S3S, suggesting that lysine interactions may lower the binding energy 
and are involved in binding. 
 
3.I.2.d. Kaempferol  Kaempferol is similar in structure to both quercetin and apigenin, 
where quercetin is a more effective inhibitor and apigenin binds weakly, therefore 
understanding the interactions between the kaempferol and CuZnSOD could explain this 
difference.  Specific trend analysis shows lysine residues oriented toward the ligand with 
Lys136 interacting more and Lys122 interacting less with kaempferol than is observed 
for the other ligands.  R-diketone tautomers show fewer interactions with Lys136 than 
enol and S-diketone forms.  Hydrogen bonding with lysine residues may influence 
binding and if this is the case, enol and S-diketone species would contribute more to 
binding than R-diketone species.   
 With kaempferol, significant interactions between the ligand and 3 and 4 position 
oxygens and either Lys136 or Arg143 are observed in 9 out of 15 poses.  An example of 
this is observed in the comparison between the enol poses with binding energies -2.12 
kcal/mol (highest for that species) and -3.29 kcal/mol (lowest for that species).  The 
highest and lowest energy enol poses share very similar ligand orientation and flexible 
amino acid orientation with the exception of Lys136.  In the lower energy pose, Lys136 is 
oriented toward the 3-hydroxyl group of kaempferol and in the less favorable pose is 
cantilevered out of the active site away from the ligand.  This clearly shows the 
importance of the Lysine interaction as it results in a 50% decrease in the binding 
energy, shown below in Figure 18. 
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Figure 18. Kaempferol Enol Species Comparison.  The -2.12 kcal/mol energy pose 
(pink) has Lys136 rotated away from kaempferol while the -3.29 kcal/mol energy pose 
(white) is stabilized through hydrogen bonding of Lys136 to the 3-OH group. 
  
3.I.2.e. Apigenin  Apigenin is a poor binder to CuZnSOD with an experimental 
dissociation constant of 2mM.30  The global trend analysis predicts apigenin to be a 
stronger binder than observed experimentally, however individual apigenin poses show 
fewer interactions than observed for the other flavonols.  Lysine 122 and 136 are turned 
away from the ligand in most poses with 2 out of 5 poses showing no interactions with 
apigenin.  The other three poses show single interactions with Arg143 or Lys136, where 
arginine hydrogen bonds with either the 1 or 7 position oxygen and lysine to the 4-
oxygen.  The lack of interactions with lysine residues or with the 3-oxygen may be 
responsible for its poor binding.  The prevalence of these interactions in other stronger 
binders suggests that they are contributors to the overall binding to CuZnSOD. 
 
3.I.3. Overall Docking Analysis 
 After individual inhibitors were assessed for hydrogen bonding and residue 
interactions, trends in binding between those inhibitors were assessed.  Several 
 
interactions were observed for flavonols across the board.  These included Lysine 122 
and Lysine 136 interactions, where Lys122 interactions were observed more for 
myricetin and quercetin and Lys136 more for taxifolin and kaempferol.  This could mean 
that Lys122 interactions result in stronger binding than Lys136 interactions. 
 Based on the analysis of 
responsible for the observed structure affinity relationship: Arg143 with the 3
position and Arg143 and lysine interactions with deprotonated 4' and 7
The interactions with Arg
previously discussed in Section 3.I.2.  Arginine 143 interactions were observed in the 
majority of poses, where interactions with the 3
to the experimental binding 
Figure 19. Poses with Arg143 and 3
 
 The correlation of poses with a specific interaction to the experimental data 
implicates that interaction in the binding of flavonols.  
interactions between Arg143 and the 3
tautomer species contributes significantly to the binding of flavonols and may explain 
poses, we believe that the following interactions are 
-position oxygens.  
143 and lysine have been observed in many poses as 
-oxygen (enol or diketone) correlate well 
data as shown in Figure 19. 
-oxygen Interactions Correlate to Experimental Data. 
Therefore, we believe that 
-position oxygen in both enol and S
61 
 
-oxygen 
 
 
-diketone 
62 
 
why apigenin is not a strong binder of CuZnSOD.  We also note the importance of 
Threonine137 in binding, as poses with Thr137 hydrogen bonding also correlated to 
experimental binding constants, suggesting that this residue may also assist in overall 
binding. 
 
3.I.4. Structure Activity Relationship 
 A qualitative structure activity relationship can be determined based on docking 
calculations and NMR experimental dissociation constants.  Experimental binding data 
shows myricetin to bind weaker below its pKa while quercetin
40 does not inhibit at all 
below its pKa, this suggests that deprotonated ligands are stronger binders.  Docking 
calculations support this, as trends in the dissociation constant were only observed for 
bis-deprotonated binding energies.  Based on these results, we believe that bis-
deprotonated ligands are the state that binds to CuZnSOD.  As the pKa of flavonols is 
approximately 7, the portion of bis-deprotonated ligand present at pH 8 is very small; 
however, the binding of the ligand to the enzyme may lower the pKa because of 
stabilization of the bis-deprotonation state.  The likely tautomer that binds to the receptor 
may be the enol or the S-diketone tautomer species as R-tautomers are generally higher 
in binding energy and have less 3-oxygen interactions for myricetin and quercetin and 
less Lys136 interactions for kaempferol. 
 The functionality necessary for CuZnSOD inhibition has been demonstrated 
experimentally.  The 3-hydroxyl group absent in the flavonol, apigenin, is necessary for 
inhibition, as apigenin does not bind where kaempferol binds strongly.  The experimental 
inhibition of CuZnSOD by taxifolin shows that the enol moiety is not necessary for 
binding but that the reduced 2-3 bond still causes some decrease in effectiveness as 
compared to quercetin.  One goal of docking was to explain this.  Interactions with both 
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the enol and diketone moieties with Arg143 in docking may explain why apigenin does 
not significantly inhibit CuZnSOD, it does not explain why quercetin is more effectively 
than taxifolin. One possibility is that the interaction of the diketone with Arg143 is 
stronger than the enol interaction, so while taxifolin still binds to Arg143, quercetin forms 
the more energetically favorable interaction explaining its lower Kd value.  Another 
interaction important to binding is the hydrogen bonding of lysine residues and Arg143 
with the deprotonated 7 and 4'- positioned oxygens.  This sandwiching of the ligand 
lowers the binding energy and would explain why the bis-deprotonated ligand binds 
stronger than the neutral and deprotonated species.  Threonine 137 is also implicated in 
binding interactions and binds in the same locations already mentioned. 
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4. CONCLUSIONS 
 
 19F NMR based assaying is an alternative to superoxide generating assays for 
measuring superoxide dismutase enzyme concentration.  We have used this method to 
screen 500 compounds quickly for CuZnSOD and MnSOD inhibition.  None were found 
to inhibit, but this experiment demonstrates the potential of the assay for high throughput 
screening.  Phytoestrogens were screened for inhibition and it was found that flavonols 
inhibit CuZnSOD in two steps, the second is only important at alkaline pH.   
 In this thesis, we have characterized the inhibition of CuZnSOD by a number of 
flavonols, 9-anthracenecarboxylic acid and acetophenones.  The pH dependence of 
inhibition is consistent with a two-step reaction.  The first inhibition step is an equilibrium 
reaction with a dissociation constant, Kd, of binding that decreases upon deprotonation 
of the inhibitors.  The second inhibition step is a slower reaction that requires 
deprotonation of the enzyme.  We found enzyme deprotonation occurs with a pKa of 
10.1, which correlates to the pKa of active site residue, Lysine 122.
36  The dependence 
of initial activity on inhibitor concentration indicates aggregation of flavonols.  
Absorbance data supported this conclusion.  Dimerization is suggested to occur more for 
deprotonated flavonols than for neutral flavonols. 
 Also examined in this thesis is the structure activity relationship of flavonol-
CuZnSOD binding.  NMR assays were used to determine the observed rate constants 
for various flavonols.  We report that taxifolin inhibited CuZnSOD, although less 
effectively than quercetin.  This result indicates that diketone tautomerization is not 
necessary for binding.  To determine whether quercetin covalently modifies CuZnSOD, 
we analyzed CuZnSOD and quercetin-saturated CuZnSOD samples using mass 
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spectrometry.  No molecular ion or fraction peaks were observed for the quercetin 
inhibited sample suggesting that the enzyme precipitated from solution after inhibition. 
 Docking calculations were performed using AutoDock 4.023 in order to predict the 
structure activity relationship of flavonols.  We hypothesize that bis-deprotonated ligands 
bind to the receptor preferentially over neutral and mono-deprotonated forms. Further, 
enol and S-diketone tautomeric forms are predicted to bind over the R-diketone form.  
Probable interactions contributing to binding are Arg143 hydrogen bonding with the 3-
oxygen and interactions of the deprotonated 4' and 7-position oxygens with Arg143 and 
lysine residues.  An observed discrepancy in the docking calculations was the prediction 
of apigenin to bind more effectively than shown in NMR experiments.  Sources of error 
include the exclusion of water38 from the active site, the inability of AutoDock to account 
for changes in metal coordination, and the exclusion of π -cation interactions.38 
 In conclusion, the inhibition of CuZnSOD by flavonols is a complex system in 
which both enzyme deprotonation and flavonol deprotonation affect binding.  Enzyme 
deprotonation is not necessary for binding.  Deprotonated flavonols are predicted to bind 
stronger by docking calculations and are observed to do so in NMR experiments.  
Deprotonated ligands are also likely to aggregate; Kd values are maxima and 
underestimate the enzyme's affinity for the inhibitor.  Our hypothesized structure activity 
relationship explains the trend in dissociation constants, but more research is needed to 
determine why quercetin inhibits more effectively than taxifolin.   
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APPENDIX 
 
A. Chalcone Structures Screened for MnSOD Inhibition 
8A 8B 
  
 
9A 9B 
  
 
10A 
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B. Dissociation Constants for CuZnSOD Inhibitors at pH 830. 
Compound Kd (mM) 
Myricetin 0.011 
Quercetin 0.024 
Taxifolin 0.150 
Kaempferol 0.160 
Apigenin 2 
DHAP 2.1 
THAP 3.5 
 
 
C. General Flavonol Structure 
 
 
 
 
 
 
 
 
                                        
D. Flavonols Screened During the Course of this Project
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